KIP Infrastructure
2.12.0 - ci-build
KIP Infrastructure, published by Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S. This guide is not an authorized publication; it is the continuous build for version 2.12.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/KIP-infrastructure/implementation-guide/ and changes regularly. See the Directory of published versions
| Active as of 2022-07-13 |
{
"resourceType" : "ValueSet",
"id" : "TreatmentRegimen",
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet TreatmentRegimen</b></p><a name=\"TreatmentRegimen\"> </a><a name=\"hcTreatmentRegimen\"> </a><ul><li>Include these codes as defined in <a href=\"CodeSystem-TreatmentRegimen.html\"><code>https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-hydrea\">hydrea</a></td><td>Hydrea</td><td>Hydrea</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-hdara_c\">hdara_c</a></td><td>HdAraC</td><td>Hd-Ara-c +- supplement</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-da31087\">da31087</a></td><td>DA inkl. 3+10, 3+8, 3+7</td><td>DA inkl. 3+10, 3+8, 3+7</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-da31087my\">da31087my</a></td><td>DA inkl. 3+10, 3+8, 3+7 + mylotarg</td><td>DA inkl. 3+10, 3+8, 3+7 + mylotarg</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-da31087mi\">da31087mi</a></td><td>DA inkl. 3+10, 3+8, 3+7 + midostaurin</td><td>DA inkl. 3+10, 3+8, 3+7 + midostaurin</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-flagmito\">flagmito</a></td><td>FLAG-Ida eller lign inkl FLAG, Mito-FLAG</td><td>FLAG-Ida eller lign inkl FLAG, Mito-FLAG</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-flagmitovene\">flagmitovene</a></td><td>FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax</td><td>FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-idarac\">idarac</a></td><td>IdAraC</td><td>IdAraC</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-apl_mt\">apl_mt</a></td><td>APL vedligehold</td><td>APL-vedligeholdsbehandling</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-azacitidinmono\">azacitidinmono</a></td><td>Azacitidin monoterapi</td><td>Azacitidin monoterapi</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-blinatumomab\">blinatumomab</a></td><td>Blinatumunab</td><td>Blinatumomab</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-vyxeos\">vyxeos</a></td><td>Vyxeos</td><td>Vyxeos +- supplement</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-nopho_2008\">nopho_2008</a></td><td>NOPHO 2008</td><td>NOPHO-2008</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-atoatra\">atoatra</a></td><td>ATO+ATRA</td><td>ATO+ATRA</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-aida\">aida</a></td><td>AIDA</td><td>AIDA</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-azacitidinvene\">azacitidinvene</a></td><td>Azacitidin-venetoclax</td><td>Azacitidin-venetoclax</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-toplusfem\">toplusfem</a></td><td>2+5 eller lign, eks. CT</td><td>2+5 eller lign, eks. CT</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-gilteritinib\">gilteritinib</a></td><td>Gilteritinib</td><td>Gilteritinib</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-midostaurin_ved\">midostaurin_ved</a></td><td>Midostaurin vedligehold</td><td>Midostaurin vedligehold</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-inotuzumab\">inotuzumab</a></td><td>Inotuzumab ozogamicin</td><td>Inotuzumab ozogamicin</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-all_ved\">all_ved</a></td><td>ALL vedligehold</td><td>ALL vedligehold</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-hyper_cvad\">hyper_cvad</a></td><td>Hyper-CVAD</td><td>Hyper-CVAD</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-alltogether_mt\">alltogether_mt</a></td><td>ALLtogether</td><td>ALLtogether</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-other_ikke\">other_ikke</a></td><td>Anden ikke-intensiv</td><td>Anden ikke-intensiv</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-other_eks\">other_eks</a></td><td>Anden eksperimentel</td><td>Anden eksperimentel</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-other_semi\">other_semi</a></td><td>Anden semiintensiv (f.eks. Plan B)</td><td>Anden semiintensiv (f.eks. Plan B)</td></tr><tr><td><a href=\"CodeSystem-TreatmentRegimen.html#TreatmentRegimen-other_int\">other_int</a></td><td>Anden intensiv (f.eks. BISHOP, Plan A)</td><td>Anden intensiv (f.eks. BISHOP, Plan A)</td></tr></table></li></ul></div>"
},
"url" : "https://kip.rkkp.dk/fhir/ValueSet/TreatmentRegimen",
"version" : "2.12.0",
"name" : "TreatmentRegimen",
"title" : "Behandlingsplan",
"status" : "active",
"experimental" : true,
"date" : "2022-07-13T00:00:00+02:00",
"publisher" : "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S",
"contact" : [
{
"name" : "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S",
"telecom" : [
{
"system" : "url",
"value" : "https://trifork.com"
},
{
"system" : "email",
"value" : "rbk@trifork.com"
}
]
}
],
"description" : "Behandlingsplan som beskriver specifikke codsering og planlægningen af behandling",
"compose" : {
"include" : [
{
"system" : "https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen",
"concept" : [
{
"code" : "hydrea",
"display" : "Hydrea"
},
{
"code" : "hdara_c",
"display" : "HdAraC"
},
{
"code" : "da31087",
"display" : "DA inkl. 3+10, 3+8, 3+7"
},
{
"code" : "da31087my",
"display" : "DA inkl. 3+10, 3+8, 3+7 + mylotarg"
},
{
"code" : "da31087mi",
"display" : "DA inkl. 3+10, 3+8, 3+7 + midostaurin"
},
{
"code" : "flagmito",
"display" : "FLAG-Ida eller lign inkl FLAG, Mito-FLAG"
},
{
"code" : "flagmitovene",
"display" : "FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax"
},
{
"code" : "idarac",
"display" : "IdAraC"
},
{
"code" : "apl_mt",
"display" : "APL vedligehold"
},
{
"code" : "azacitidinmono",
"display" : "Azacitidin monoterapi"
},
{
"code" : "blinatumomab",
"display" : "Blinatumunab"
},
{
"code" : "vyxeos",
"display" : "Vyxeos"
},
{
"code" : "nopho_2008",
"display" : "NOPHO 2008"
},
{
"code" : "atoatra",
"display" : "ATO+ATRA"
},
{
"code" : "aida",
"display" : "AIDA"
},
{
"code" : "azacitidinvene",
"display" : "Azacitidin-venetoclax"
},
{
"code" : "toplusfem",
"display" : "2+5 eller lign, eks. CT"
},
{
"code" : "gilteritinib",
"display" : "Gilteritinib"
},
{
"code" : "midostaurin_ved",
"display" : "Midostaurin vedligehold"
},
{
"code" : "inotuzumab",
"display" : "Inotuzumab ozogamicin"
},
{
"code" : "all_ved",
"display" : "ALL vedligehold"
},
{
"code" : "hyper_cvad",
"display" : "Hyper-CVAD"
},
{
"code" : "alltogether_mt",
"display" : "ALLtogether"
},
{
"code" : "other_ikke",
"display" : "Anden ikke-intensiv"
},
{
"code" : "other_eks",
"display" : "Anden eksperimentel"
},
{
"code" : "other_semi",
"display" : "Anden semiintensiv (f.eks. Plan B)"
},
{
"code" : "other_int",
"display" : "Anden intensiv (f.eks. BISHOP, Plan A)"
}
]
}
]
}
}